• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于U统计量理论的ΔAUC、NRI和IDI的渐近分布。

Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.

作者信息

Demler Olga V, Pencina Michael J, Cook Nancy R, D'Agostino Ralph B

机构信息

Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue, Boston, MA, 02115, U.S.A.

Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, 27708, U.S.A.

出版信息

Stat Med. 2017 Sep 20;36(21):3334-3360. doi: 10.1002/sim.7333. Epub 2017 Jun 19.

DOI:10.1002/sim.7333
PMID:28627112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5931715/
Abstract

The change in area under the curve (∆AUC), the integrated discrimination improvement (IDI), and net reclassification index (NRI) are commonly used measures of risk prediction model performance. Some authors have reported good validity of associated methods of estimating their standard errors (SE) and construction of confidence intervals, whereas others have questioned their performance. To address these issues, we unite the ∆AUC, IDI, and three versions of the NRI under the umbrella of the U-statistics family. We rigorously show that the asymptotic behavior of ∆AUC, NRIs, and IDI fits the asymptotic distribution theory developed for U-statistics. We prove that the ∆AUC, NRIs, and IDI are asymptotically normal, unless they compare nested models under the null hypothesis. In the latter case, asymptotic normality and existing SE estimates cannot be applied to ∆AUC, NRIs, or IDI. In the former case, SE formulas proposed in the literature are equivalent to SE formulas obtained from U-statistics theory if we ignore adjustment for estimated parameters. We use Sukhatme-Randles-deWet condition to determine when adjustment for estimated parameters is necessary. We show that adjustment is not necessary for SEs of the ∆AUC and two versions of the NRI when added predictor variables are significant and normally distributed. The SEs of the IDI and three-category NRI should always be adjusted for estimated parameters. These results allow us to define when existing formulas for SE estimates can be used and when resampling methods such as the bootstrap should be used instead when comparing nested models. We also use the U-statistic theory to develop a new SE estimate of ∆AUC. Copyright © 2017 John Wiley & Sons, Ltd.

摘要

曲线下面积变化(∆AUC)、综合判别改善(IDI)和净重新分类指数(NRI)是常用的风险预测模型性能度量指标。一些作者报告了估计其标准误差(SE)和构建置信区间的相关方法具有良好的有效性,而另一些作者则对其性能提出了质疑。为了解决这些问题,我们将∆AUC、IDI和三个版本的NRI统一在U统计量族的框架下。我们严格证明了∆AUC、NRI和IDI的渐近行为符合为U统计量发展的渐近分布理论。我们证明了∆AUC、NRI和IDI渐近正态,除非它们在原假设下比较嵌套模型。在后一种情况下,渐近正态性和现有的SE估计不能应用于∆AUC、NRI或IDI。在前一种情况下,如果我们忽略对估计参数的调整,文献中提出的SE公式与从U统计量理论获得的SE公式等价。我们使用Sukhatme-Randles-deWet条件来确定何时需要对估计参数进行调整。我们表明,当添加的预测变量显著且呈正态分布时,∆AUC和两个版本的NRI的SE不需要调整。IDI和三类NRI的SE应始终对估计参数进行调整。这些结果使我们能够确定何时可以使用现有的SE估计公式,以及在比较嵌套模型时何时应使用诸如自助法等重采样方法。我们还使用U统计量理论开发了一种新的∆AUC的SE估计。版权所有© 2017约翰威立父子有限公司。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/a59193286598/nihms908139f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/915056670973/nihms908139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/05737e9445ff/nihms908139f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/5c7aaba93008/nihms908139f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/096af299f813/nihms908139f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/d3abf24412cf/nihms908139f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/a59193286598/nihms908139f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/915056670973/nihms908139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/05737e9445ff/nihms908139f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/5c7aaba93008/nihms908139f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/096af299f813/nihms908139f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/d3abf24412cf/nihms908139f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f65d/5931715/a59193286598/nihms908139f6.jpg

相似文献

1
Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.基于U统计量理论的ΔAUC、NRI和IDI的渐近分布。
Stat Med. 2017 Sep 20;36(21):3334-3360. doi: 10.1002/sim.7333. Epub 2017 Jun 19.
2
Clinical risk reclassification at 10 years.10年时的临床风险重新分类
Stat Med. 2017 Dec 10;36(28):4498-4502. doi: 10.1002/sim.7340.
3
Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.使用多种性能指标评估多基因风险模型:对不一致结果的批判性评估。
Genet Med. 2019 Feb;21(2):391-397. doi: 10.1038/s41436-018-0058-9. Epub 2018 Jun 12.
4
Inference for reclassification statistics under nested and non-nested models for biomarker evaluation.用于生物标志物评估的嵌套和非嵌套模型下重新分类统计量的推断。
Biomarkers. 2015;20(4):240-52. doi: 10.3109/1354750X.2015.1068854.
5
Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.评估多个遗传风险评分模型对结直肠癌风险预测的影响。
Gene. 2018 Oct 5;673:174-180. doi: 10.1016/j.gene.2018.06.035. Epub 2018 Jun 14.
6
Bayesian reclassification statistics for assessing improvements in diagnostic accuracy.用于评估诊断准确性改善情况的贝叶斯重新分类统计
Stat Med. 2016 Jul 10;35(15):2574-92. doi: 10.1002/sim.6899. Epub 2016 Feb 14.
7
A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.关于新型生物标志物评估的一则注释:不要依赖综合判别改善和净重新分类指数。
Stat Med. 2014 Aug 30;33(19):3405-14. doi: 10.1002/sim.5804. Epub 2013 Apr 2.
8
Simpson's paradox in the integrated discrimination improvement.综合鉴别改善中的辛普森悖论。
Stat Med. 2017 Dec 10;36(28):4468-4481. doi: 10.1002/sim.6862. Epub 2016 Jan 5.
9
First things first: risk model performance metrics should reflect the clinical application.首先:风险模型性能指标应反映临床应用情况。
Stat Med. 2017 Dec 10;36(28):4503-4508. doi: 10.1002/sim.7341.
10
Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.多变量正态性下嵌套和非嵌套模型预后改善评估的措施。
Stat Med. 2019 Sep 10;38(20):3817-3831. doi: 10.1002/sim.8204. Epub 2019 Jun 18.

引用本文的文献

1
Berg Balance Scale score is a valuable predictor of all-cause mortality among acute decompensated heart failure patients.伯格平衡量表评分是急性失代偿性心力衰竭患者全因死亡率的重要预测指标。
J Geriatr Cardiol. 2025 May 28;22(6):555-562. doi: 10.26599/1671-5411.2025.06.003.
2
Interrelationships Between Inflammatory Score, Delayed Cerebral Ischemia and Unfavorable Outcome in Patients with aSAH: A Four-Way Decomposition.动脉瘤性蛛网膜下腔出血患者炎症评分、迟发性脑缺血与不良预后之间的相互关系:四向分解
J Inflamm Res. 2024 Dec 14;17:11073-11085. doi: 10.2147/JIR.S481066. eCollection 2024.
3
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.

本文引用的文献

1
Discrimination slope and integrated discrimination improvement - properties, relationships and impact of calibration.鉴别斜率与综合鉴别改善——校准的特性、关系及影响
Stat Med. 2017 Dec 10;36(28):4482-4490. doi: 10.1002/sim.7139. Epub 2016 Oct 3.
2
Net reclassification index at event rate: properties and relationships.事件发生率下的净重新分类指数:特性与关系
Stat Med. 2017 Dec 10;36(28):4455-4467. doi: 10.1002/sim.7041. Epub 2016 Jul 18.
3
RE: net risk reclassification P Values: valid or misleading?关于:净风险重新分类P值:有效还是误导?
M2BPGi 的定量测量取决于肝纤维化和炎症。
J Gastroenterol. 2024 Jul;59(7):598-608. doi: 10.1007/s00535-024-02100-3. Epub 2024 Apr 16.
4
A Modified Net Reclassification Improvement Statistic.一种改良的净重新分类改善统计量。
J Stat Plan Inference. 2023 Dec;227:18-33. doi: 10.1016/j.jspi.2023.03.001. Epub 2023 Mar 11.
5
A Prediction Nomogram Combining Epworth Sleepiness Scale and Other Clinical Parameters to Predict Obstructive Sleep Apnea in Patients with Hypertension.一种结合爱泼华嗜睡量表及其他临床参数预测高血压患者阻塞性睡眠呼吸暂停的预测列线图。
Int J Hypertens. 2022 Aug 5;2022:3861905. doi: 10.1155/2022/3861905. eCollection 2022.
6
Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.丝氨酸蛋白酶抑制剂 Kazal 型 1,一种潜在的生物标志物,用于早期检测、靶向和预测肝细胞癌对免疫检查点阻断治疗的反应。
Front Immunol. 2022 Jul 18;13:923031. doi: 10.3389/fimmu.2022.923031. eCollection 2022.
7
Number of Positive Lymph Nodes Combined with the Logarithmic Ratio of Positive Lymph Nodes predicts Survival in Patients with Non-Metastatic Larynx Squamous Cell Carcinoma.阳性淋巴结数量联合阳性淋巴结对数比值可预测非转移性喉鳞状细胞癌患者的生存情况。
J Cancer. 2022 Mar 14;13(6):1773-1784. doi: 10.7150/jca.67348. eCollection 2022.
8
Efficiency of Monocyte/High-Density Lipoprotein Cholesterol Ratio Combined With Neutrophil/Lymphocyte Ratio in Predicting 28-Day Mortality in Patients With Sepsis.单核细胞/高密度脂蛋白胆固醇比值联合中性粒细胞/淋巴细胞比值预测脓毒症患者28天死亡率的效能
Front Med (Lausanne). 2021 Oct 13;8:741015. doi: 10.3389/fmed.2021.741015. eCollection 2021.
9
Effects of Neutrophil-to-Lymphocyte Ratio Combined With Interleukin-6 in Predicting 28-Day Mortality in Patients With Sepsis.中性粒细胞与淋巴细胞比值联合白细胞介素-6预测脓毒症患者 28 天病死率的效果。
Front Immunol. 2021 Mar 16;12:639735. doi: 10.3389/fimmu.2021.639735. eCollection 2021.
10
Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes.量化用于竞争风险结局的新型生物标志物的诊断准确性改善情况。
Biostatistics. 2020 Feb 21;23(2):666-82. doi: 10.1093/biostatistics/kxaa048.
J Natl Cancer Inst. 2014 Nov 27;107(1):355. doi: 10.1093/jnci/dju355. Print 2015 Jan.
4
What to expect from net reclassification improvement with three categories.对于三类净重新分类改善情况的预期。
Stat Med. 2014 Dec 10;33(28):4975-87. doi: 10.1002/sim.6286. Epub 2014 Aug 31.
5
Net reclassification indices for evaluating risk prediction instruments: a critical review.用于评估风险预测工具的净重新分类指数:批判性评价。
Epidemiology. 2014 Jan;25(1):114-21. doi: 10.1097/EDE.0000000000000018.
6
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南:美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
7
Testing for improvement in prediction model performance.评估预测模型性能的改善情况。
Stat Med. 2013 Apr 30;32(9):1467-82. doi: 10.1002/sim.5727. Epub 2013 Jan 7.
8
A bias-corrected net reclassification improvement for clinical subgroups.临床亚组的校正偏倚净重新分类改善。
Med Decis Making. 2013 Feb;33(2):154-62. doi: 10.1177/0272989X12461856. Epub 2012 Oct 5.
9
Comparing ROC curves derived from regression models.比较回归模型得出的 ROC 曲线。
Stat Med. 2013 Apr 30;32(9):1483-93. doi: 10.1002/sim.5648. Epub 2012 Oct 3.
10
Misuse of DeLong test to compare AUCs for nested models.误用 Delong 检验比较嵌套模型的 AUC。
Stat Med. 2012 Oct 15;31(23):2577-87. doi: 10.1002/sim.5328. Epub 2012 Mar 13.